Ubiquitin in the activation and attenuation of innate antiviral immunity

181Citations
Citations of this article
204Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Viral infection activates danger signals that are transmitted via the retinoic acid-inducible gene 1-like receptor (RLR), nucleotide- binding oligomerization domain-like receptor (NLR), and Toll-like receptor (TLR) protein signaling cascades. This places host cells in an antiviral posture by up-regulating antiviral cytokines including type-I interferon (IFN-I). Ubiquitin modifications and cross-talk between proteins within these signaling cascades potentiate IFN-I expression, and inversely, a growing number of viruses are found to weaponize the ubiquitin modification system to suppress IFN-I. Here we review how host- and virus-directed ubiquitin modification of proteins in the RLR, NLR, and TLR antiviral signaling cascades modulate IFN-I expression.

Cite

CITATION STYLE

APA

Heaton, S. M., Borg, N. A., & Dixit, V. M. (2016, January 11). Ubiquitin in the activation and attenuation of innate antiviral immunity. Journal of Experimental Medicine. Rockefeller University Press. https://doi.org/10.1084/jem.20151531

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free